Last reviewed · How we verify

NCT07090512

Multimodal Ultrasound in DBD Kidneys for Predicting Early Postoperative Renal Insufficiency Risk

Recruiting now Last updated 29 July 2025
What this trial tests

trial testing Multimodal Ultrasound in Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation in 27 participants. Currently enrolling.

Timeline
1 January 2025
Primary endpoint
31 December 2025
31 March 2026

Quick facts

Lead sponsorBei Wang
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment27
Start date1 January 2025
Primary completion31 December 2025
Estimated completion31 March 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Bei Wang

Who can join

18 and older, any sex, with Occurrence of Renal Dysfunction (GFR ≤ 60mL/(Min·1.73m2)) in Renal Transplant Recipients Within One Year After Kidney Transplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this observational study is to investigate the multimodal ultrasound parameters of kidneys from brain-dead organ donors prior to donation, in order to construct a predictive model for assessing the risk of early transplant renal dysfunction after kidney transplantation in recipients. The primary question this study aims to address is: Can multimodal ultrasound data from brain-dead organ donor kidneys accurately predict early post-transplant renal dysfunction? Ultrasonography, as a routine examination before organ donation, will be utilized, and the study results will be concluded within one year after participation in this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Multimodal Ultrasound

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07090512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing